tm logo

Monitor this mark

View On USPTO

OCTAPHARMA
Live/Registered
REGISTERED AND RENEWED

on 27 Dec 2024

Last Applicant/ Owned by

Octapharma AG

Seidenstrasse 2

Lachen

CH

CH-8853

Serial Number

76314715 filed on 20th Sep 2001

Registration Number

2938519 registered on 05th Apr 2005

in the Principal Register

Correspondent Address

Marie-Anne Mastrovito

Marie-Anne Mastrovito Womble Bond Dickinson (US) LLP

New York, NY 10022

United States

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

OCTAPHARMA

Pharmaceutical products, namely blood plasma derivatives in the nature of virus inactivated blood plasma, blood clotting factors, immunoglobulins

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical products, namely blood plasma derivatives in the nature of virus inactivated blood plasma, blood clotting factors, immunoglobulins

First Use Date in General

30th Jun 2004

First Use Date in Commerce

30th Jun 2004

Mark Details

Serial Number

No 76314715

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 116765.00081

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
27th Dec 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
27th Dec 2024REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
27th Dec 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
27th Dec 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
13th Sep 2024TEAS SECTION 8 & 9 RECEIVED
05th Apr 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
09th Apr 2015REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
09th Apr 2015REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09th Apr 2015CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09th Apr 2015NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED